These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 14683429)

  • 1. The biphasic virulence activities of gingipains: activation and inactivation of host proteins.
    Imamura T; Travis J; Potempa J
    Curr Protein Pept Sci; 2003 Dec; 4(6):443-50. PubMed ID: 14683429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of gingipains in the pathogenesis of periodontal disease.
    Imamura T
    J Periodontol; 2003 Jan; 74(1):111-8. PubMed ID: 12593605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire.
    O-Brien-Simpson NM; Veith PD; Dashper SG; Reynolds EC
    Curr Protein Pept Sci; 2003 Dec; 4(6):409-26. PubMed ID: 14683427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pathogenic properties between two types of arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis.
    Imamura T; Potempa J; Travis J
    Microb Pathog; 2000 Sep; 29(3):155-63. PubMed ID: 10968947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes.
    Potempa J; Sroka A; Imamura T; Travis J
    Curr Protein Pept Sci; 2003 Dec; 4(6):397-407. PubMed ID: 14683426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of virulence of Porphyromonas gingivalis by potent inhibitors specific for gingipains.
    Kadowaki T; Yamamoto K
    Curr Protein Pept Sci; 2003 Dec; 4(6):451-8. PubMed ID: 14683430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis.
    Mezyk-Kopec R; Bzowska M; Potempa J; Bzowska M; Jura N; Sroka A; Black RA; Bereta J
    Infect Immun; 2005 Mar; 73(3):1506-14. PubMed ID: 15731048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of lys-gingipain protease activity in Porphyromonas gingivalis W50 is independent of Arg-gingipain protease activities.
    Aduse-Opoku J; Davies NN; Gallagher A; Hashim A; Evans HEA; Rangarajan M; Slaney JM; Curtis MA
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1933-1940. PubMed ID: 10931897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.
    Genco CA; Potempa J; Mikolajczyk-Pawlinska J; Travis J
    Clin Infect Dis; 1999 Mar; 28(3):456-65. PubMed ID: 10194062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity.
    Lourbakos A; Yuan YP; Jenkins AL; Travis J; Andrade-Gordon P; Santulli R; Potempa J; Pike RN
    Blood; 2001 Jun; 97(12):3790-7. PubMed ID: 11389018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis.
    Imamura T; Potempa J; Pike RN; Travis J
    Infect Immun; 1995 May; 63(5):1999-2003. PubMed ID: 7729914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis.
    Inagaki S; Ishihara K; Yasaki Y; Yamada S; Okuda K
    J Periodontol; 2003 Oct; 74(10):1432-9. PubMed ID: 14653388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains.
    Katz J; Yang QB; Zhang P; Potempa J; Travis J; Michalek SM; Balkovetz DF
    Infect Immun; 2002 May; 70(5):2512-8. PubMed ID: 11953390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness.
    Sugawara S; Nemoto E; Tada H; Miyake K; Imamura T; Takada H
    J Immunol; 2000 Jul; 165(1):411-8. PubMed ID: 10861079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.
    Imamura T; Matsushita K; Travis J; Potempa J
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2871-6. PubMed ID: 11557483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of Arg- and Lys-gingipains in coaggregation of Porphyromonas gingivalis: identification of its responsible molecules in translation products of rgpA, kgp, and hagA genes.
    Abe N; Baba A; Takii R; Nakayama K; Kamaguchi A; Shibata Y; Abiko Y; Okamoto K; Kadowaki T; Yamamoto K
    Biol Chem; 2004 Nov; 385(11):1041-7. PubMed ID: 15576324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the specificity of arginine-specific gingipains from Porphyromonas gingivalis reveals active site differences between different forms of the enzymes.
    Ally N; Whisstock JC; Sieprawska-Lupa M; Potempa J; Le Bonniec BF; Travis J; Pike RN
    Biochemistry; 2003 Oct; 42(40):11693-700. PubMed ID: 14529279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.
    O'Brien-Simpson NM; Paolini RA; Hoffmann B; Slakeski N; Dashper SG; Reynolds EC
    Infect Immun; 2001 Dec; 69(12):7527-34. PubMed ID: 11705929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of vascular endothelial thrombomodulin by arginine- and lysine-specific cysteine proteases from Porphyromonas gingivalis.
    Inomata M; Ishihara Y; Matsuyama T; Imamura T; Maruyama I; Noguchi T; Matsushita K
    J Periodontol; 2009 Sep; 80(9):1511-7. PubMed ID: 19722803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, potent dual inhibitor of Arg-gingipains and Lys-gingipain as a promising agent for periodontal disease therapy.
    Kataoka S; Baba A; Suda Y; Takii R; Hashimoto M; Kawakubo T; Asao T; Kadowaki T; Yamamoto K
    FASEB J; 2014 Aug; 28(8):3564-78. PubMed ID: 24776743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.